1. Home
  2. BDTX vs CLDT Comparison

BDTX vs CLDT Comparison

Compare BDTX & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • CLDT
  • Stock Information
  • Founded
  • BDTX 2014
  • CLDT 2009
  • Country
  • BDTX United States
  • CLDT United States
  • Employees
  • BDTX N/A
  • CLDT N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • CLDT Real Estate Investment Trusts
  • Sector
  • BDTX Health Care
  • CLDT Real Estate
  • Exchange
  • BDTX Nasdaq
  • CLDT Nasdaq
  • Market Cap
  • BDTX 323.2M
  • CLDT 428.0M
  • IPO Year
  • BDTX 2020
  • CLDT 2010
  • Fundamental
  • Price
  • BDTX $3.22
  • CLDT $8.65
  • Analyst Decision
  • BDTX Strong Buy
  • CLDT Buy
  • Analyst Count
  • BDTX 4
  • CLDT 1
  • Target Price
  • BDTX $15.50
  • CLDT $12.00
  • AVG Volume (30 Days)
  • BDTX 2.5M
  • CLDT 251.3K
  • Earning Date
  • BDTX 11-04-2024
  • CLDT 11-07-2024
  • Dividend Yield
  • BDTX N/A
  • CLDT 3.24%
  • EPS Growth
  • BDTX N/A
  • CLDT N/A
  • EPS
  • BDTX N/A
  • CLDT N/A
  • Revenue
  • BDTX N/A
  • CLDT $312,832,000.00
  • Revenue This Year
  • BDTX N/A
  • CLDT N/A
  • Revenue Next Year
  • BDTX N/A
  • CLDT $3.58
  • P/E Ratio
  • BDTX N/A
  • CLDT N/A
  • Revenue Growth
  • BDTX N/A
  • CLDT 1.26
  • 52 Week Low
  • BDTX $1.62
  • CLDT $7.60
  • 52 Week High
  • BDTX $7.66
  • CLDT $11.32
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 28.22
  • CLDT 56.72
  • Support Level
  • BDTX $3.27
  • CLDT $8.15
  • Resistance Level
  • BDTX $3.49
  • CLDT $8.67
  • Average True Range (ATR)
  • BDTX 0.25
  • CLDT 0.15
  • MACD
  • BDTX -0.01
  • CLDT 0.01
  • Stochastic Oscillator
  • BDTX 6.92
  • CLDT 96.15

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest

Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.

Share on Social Networks: